Healio (4/26, Welsh) reports, “Among women with a history [of] depression, risk for postpartum depression was greater for those whose prior depression was associated with use of hormonal contraception, according to a cohort study.”

MedPage Today (4/26) reports that investigators found, “in the analysis of over 188,000 first-time mothers who had used hormonal contraception (HC) in the past, those with a history of HC-related depression had a 35% higher chance of experiencing postpartum depression than those with a history of depression not related to HC.” The findings were published online April 26 in JAMA Psychiatry.

Related Links:

— “Hormonal contraception-associated depression linked to higher postpartum depression risk “Erin T. Welsh, Healio, April 26, 2023

HealthDay (4/25, Murez) reports 67% of Americans over 50 said in a poll that they were interested in cutting back on prescription medications. The findings are in line with a growing movement toward “deprescribing.” However, researchers “emphasized that it’s important for patients and providers to communicate about deprescribing.”

Related Links:

— “Lots of Older Americans Would Like to Take Fewer Meds, Poll Finds “Cara Murez, HealthDay, April 25, 2023

Psych News Alert (4/25) reports, “People with early psychosis (those who have had only a single episode of psychosis) who experience persistent sleep problems are nearly 14 times as likely to report suicidal ideation as those with early psychosis who do not experience sleep problems, according to” research. Investigators found, after analyzing data on 403 people, that “sleep problems were associated with significantly increased odds of suicidal ideation at baseline and 18 months.” Additionally, “sleep problems at any time point were associated with an over a threefold increased odds of suicidal ideation.” The findings were published online April 22 in Schizophrenia Bulletin.

Related Links:

— “Suicidal Thoughts Linked to Sleep Problems in Patients With Early Psychosis, Psych News Alert, April 25, 2023

The Washington Post (4/25, Amenabar) reports that research shows that “the chewy melatonin gummies that many people take before bedtime to promote sleep may contain far more of the hormone than what’s printed on the label.”

The New York Times (4/25, Blum) reports that investigators “analyzed 25 melatonin gummy products from different brands and found that 22 contained different amounts of melatonin than what was listed on their labels; one contained only 74 percent of the advertised amount of melatonin, while another had 347 percent more.” Meanwhile, “another product contained no detectable melatonin at all.” The findings were published online April 25 in a research letter in JAMA.

Also covering the story are MedPage Today (4/25, George) and HealthDay (4/25, Norton).

Related Links:

— “The Washington Post (requires login and subscription)

Healio (4/22, Young) reported, “People who experienced lifetime and everyday discrimination had elevated risk for cardiovascular and all-cause mortality compared with those who did not,” investigators concluded in findings published online ahead of print in the journal Circulation: Cardiovascular Quality and Outcomes. For the study, “researchers followed participants from the MESA cohort aged 45 to 84 years without a history of CVD (1,633 Black, 1,403 Hispanic/Latino and 2,473 white) across five exams from 2002 to 2018.”

Related Links:

— “Experience with discrimination may increase cardiovascular, all-cause mortality “Kate Young, Healio , April 22, 2023

According to HCPlive (4/21, Walter), research indicates that “patients with cystic fibrosis or primary ciliary dyskinesia, as well as their caregivers, were at an increased risk of developing mental illnesses like depression or anxiety during the ongoing COVID-19 pandemic.” Included in the 110-patient study were “110 patients, 10 with cystic fibrosis, 31 with primary ciliary dyskinesia, 52 cystic fibrosis caregivers, and 17 primary ciliary dyskinesia caregivers.” The findings were published online April 21 in the journal Pediatric Pulmonology.

Related Links:

— “Caregivers, Patients With Cystic Fibrosis, Primary Ciliary Dyskinesia at Elevated Risk of Mental Illness “Kenny Walter, HCPlive, April 21, 2023

Healio (4/20, Firment) reported, “Young people with schizophrenia had elevated risk for sudden cardiac death, and biopsychosocial factors related to social isolation impacted the cardiac risk factor burden in individuals with schizophrenia, researchers” concluded in a study also revealing that “among young people with sudden cardiac death who were referred for autopsy, individuals with schizophrenia were more likely to have nonischemic cardiomyopathy compared with individuals without schizophrenia.” The findings of the 579-individual postmortem study were published online in the journal JACC: Clinical Electrophysiology.

Related Links:

— “Schizophrenic individuals have increased risk for sudden cardiac death “Hunter Firment, Healio, April 20, 2023

CNN (4/20, Christensen) reports, “The rate of suspected suicides and suicide attempts by poisoning among young people rose sharply during the Covid-19 pandemic,” with the rate increasing 73% “from 2019 to 2021” in “children 10 to 12 years old,” according to an analysis published online April 21 in the CDC’s Morbidity and Mortality Weekly Report. The study examined “what the National Poison Data System categorized as ‘suspected suicides’ by self-poisoning for 2021 among people ages 10 to 19; the records included both suicide attempts and deaths by suicide.” The data revealed that “attempted suicides and suicides by poisoning increased 30% in 2021 compared with 2019, before the pandemic began.”

Related Links:

— “Suicides and suicide attempts by poisoning rose sharply among children and teens during the pandemic “Jen Christensen, CNN , April 20, 2023

Healio (4/20, Southall) reports, “A depression diagnosis before and after a breast cancer diagnosis appeared associated with worse survival outcomes, according to study results.” The research indicates “that early detection and continued management of depression are imperative to improve patient survival, researchers concluded.” The findings were published in Cancer.

Related Links:

— “Depression before, after diagnosis linked to higher risk for breast cancer death “Jennifer Southall, Healio , April 20, 2023

HealthDay (4/20, Thompson) reports, “Suspected suicide attempts linked to marijuana overdoses have been steadily increasing over the past decade,” investigators concluded.

HCPlive (4/20, Walter) reports researchers “described suicidal cannabis exposures reported to US poison centers between 2009-2021 and compared case characteristics before and during the pandemic.” They then examined some “18,698 intentional, suspected suicidal cannabis exposures between 2009-2021.” The findings were published online April 19 in a research letter in JAMA Network Open.

Related Links:

— “Could Better Access to Marijuana Be Linked to Rising Suicide Rates? “Dennis Thompson, HealthDay, April 20, 2023